BALDRY MARK (Chief Commercial Officer) sold 29.4% of their position (10.26K shares) of X4 PHARMACEUTICALS, INC on the open market
Open‑market sale worth $7.5K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/3/2023ACC: 0001628280-23-036756
Officer· Chief Commercial Officer
Since Nov 2022
-10.26K
Net shares
Net seller
$7.5K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
10.26K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−10.26K
Price / share
$0.73
Trade value
$7.49K
% of position
29.4%
11/1/2023
34.95K→24.69K
Total
Net shares
−10.26K
Net value
-$7.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/1/2023 | S · Sale | −10.26K | $0.73 | $7.49K | 29.4% | 34.95K | 24.69K |
| Total | −10.26K | -$7.49K | ||||||
Derivative Transactions0
No derivative transactions reported